EZZ Life Science Holdings Limited (ASX:EZZ)
Australia · Delayed Price · Currency is AUD 0.6320
+0.0370 (6.22%)
May 29, 2026, 1:34 PM AEST
EZZ Life Science Holdings Market Cap
EZZ Life Science Holdings has a market cap or net worth of 29.75 million as of May 29, 2026. Its market cap has decreased by -59.32% in one year.
Market Cap
29.75M
Enterprise Value
15.19M
Revenue
61.40M
Ranking
n/a
PE Ratio
10.30
Stock Price
0.63
Market Cap Chart
Since March 3, 2021, EZZ Life Science Holdings's market cap has decreased from 48.72M to 29.75M, a decrease of -38.94%. That is a compound annual growth rate of -8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 29.75M | -55.15% |
| Dec 31, 2025 | 66.33M | -54.20% |
| Dec 31, 2024 | 144.82M | 421.72% |
| Dec 29, 2023 | 27.76M | 73.11% |
| Dec 30, 2022 | 16.04M | -26.47% |
| Dec 31, 2021 | 21.81M | -55.24% |
| Mar 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 53.85M |
| Nexsen | 51.05M |
| Imugene | 47.82M |
| Neurizon Therapeutics | 46.27M |
| Avecho Biotechnology | 45.97M |
| NeuroScientific Biopharmaceuticals | 30.60M |
| Patrys | 30.00M |
| Noxopharm | 26.42M |